Related Experiment Video
Updated: Aug 9, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Association between tazobactam-piperacillin exposure and the subsequent emergence in gram-negative rods: Findings
Ezaki Masayoshi1, Kato Noriko2, Nagaoka Kentaro1
1Department of Clinical Infectious Diseases, Toyama University Hospital, Toyama, Japan.
Background:
The impact of tazobactam-piperacillin (TZP) exposure on subsequent resistance development remains unclear. We evaluated the association between TZP treatment duration and the emergence of TZP-resistant gram-negative rods (GNRs).
Methods:
This single-institution retrospective observational study included all patients who received TZP at Toyama University Hospital (January 2021-December 2023). The primary outcome was the emergence of new TZP-resistant GNRs of interest, including Pseudomonas aeruginosa and Enterobacterales, within 180 days of the index exposure. Death was treated as a competing risk. Multivariable Fine-Gray regression analysis identified independent risk factors.
Results:
Among 1619 patients treated with TZP, 96 (5.9%) developed new TZP-resistant GNRs within 180 days. The cumulative incidence was higher in patients exposed to TZP for ≥14 days (12.0%). TZP-resistant isolates comprised P. aeruginosa (28%) and AmpC-producing Enterobacterales (42%). In multivariable analysis, prolonged TZP exposure (≥14 days) was independently associated with resistance emergence (adjusted subdistribution hazard ratio 1.73; 95% confidence interval 1.03-2.89). Additional independent risk factors included the initial isolation of P. aeruginosa or AmpC-producing Enterobacterales without baseline TZP resistance and specific infection foci or clinical conditions.
Conclusions:
Prolonged TZP exposure (≥14 days) was an independent risk factor for the subsequent emergence of TZP-resistant GNRs. Baseline microbiological characteristics also influenced resistance development. These findings support optimization of TZP treatment duration within antimicrobial stewardship programs to mitigate resistance emergence.
Insights
Prolonged exposure to tazobactam-piperacillin (TZP) for 14 days or more increases the risk of developing resistant gram-negative rods (GNRs). Optimizing TZP duration is key to antimicrobial stewardship.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Antimicrobial Resistance
Background:
- The relationship between tazobactam-piperacillin (TZP) exposure and the development of subsequent antimicrobial resistance is not well understood.
- Gram-negative rods (GNRs) are a significant cause of hospital-acquired infections, and resistance to commonly used antibiotics like TZP is a growing concern.
Purpose of the Study:
- To investigate the association between the duration of TZP treatment and the emergence of TZP-resistant GNRs.
- To identify independent risk factors for the development of TZP resistance in GNRs.
Main Methods:
- A retrospective observational study was conducted at a single institution.
- Data from 1,619 patients treated with TZP between January 2021 and December 2023 were analyzed.
- Multivariable Fine-Gray regression was used to identify risk factors for new TZP-resistant GNRs within 180 days of exposure.
Main Results:
- 5.9% of patients developed new TZP-resistant GNRs within 180 days.
- Patients receiving TZP for ≥14 days had a higher cumulative incidence of resistance (12.0%).
- Prolonged TZP exposure (≥14 days) was an independent risk factor (aSHR 1.73; 95% CI 1.03-2.89).
- Pseudomonas aeruginosa and AmpC-producing Enterobacterales were common resistant isolates.
Conclusions:
- Extended TZP treatment duration (≥14 days) is an independent predictor of subsequent TZP-resistant GNR emergence.
- Initial microbiological findings and specific clinical factors also contribute to resistance development.
- Antimicrobial stewardship programs should focus on optimizing TZP treatment duration to combat resistance.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management